MedPath

Feasibility, Acceptability and the Effects of Two Publicly Available Physical Activity Mobile Apps

Not Applicable
Completed
Conditions
PHYSICAL FITNESS
Registration Number
NCT03565627
Lead Sponsor
University College, London
Brief Summary

Within the new digital health care landscape, the rise of health applications (apps) creates novel prospects for behaviour change opportunities. The commercial market is saturated with apps that aim to increase physical activity (PA) with more than 49,000 PA apps available in the major app stores in 2016 \[1\]. Despite the wide distribution and popularity of PA apps, research on the efficacy of the apps is lacking.

This project focuses on exploring the potential for increasing PA levels using 2 selected apps that are available on the market with participants that do not engage or perform very little PA. This study is timely because PA apps on the market are extremely popular and there is a clear need to this the potential of these potentially convenient, accessible, wide-reaching, and cost-effective technology.

Before a large scale study is conducted, it is crucial to conduct assessment of the feasibility and acceptability of the study \[2\]. Feasibility determines if the study design, procedures, and the intervention can be executed by the researcher. Acceptability assesses the suitability of the study design, procedures, and the intervention from the perspective of the participants and intervention deliverers \[3\]. Hence, this mixed-methods feasibility study was designed to inform a decision about whether to proceed to a large-scale study. The aim of this study is to investigate the feasibility and acceptability of a study assessing 2 selected PA apps to inform the design of a definitive RCT, and to assess the effects of the app interventions on PA

Detailed Description

The aim of this research project is to investigate the feasibility and acceptability of a study assessing 2 selected PA apps to inform the design of a definitive randomised controlled trial, and to assess the effects of the app interventions on PA.

To address the aim, an explanatory mixed-methods study using quantitative (phase 1) and qualitative (phase 2) design will be used. Target population will be those that do not engage, or engage in low levels, of PA and the investigators will aim at recruiting participants from London and surrounding areas.

The primary objective is to determine the feasibility and acceptability of the trial procedures and the interventions delivered using apps.

The secondary objectives are to explore potential effects of the 2 selected PA apps on behavioural and psychological outcomes, and to assess the usability of the apps.

Phase 1 Phase 1 will utilise a crossover which means that half of the participants will be randomly assigned to use 1 of the 2 apps, while the other half will use the 2nd app. After 2 weeks participants will switch.

Participants will complete a baseline assessment (1 week), followed by the randomisation to using 1 of the 2 apps (2 weeks' follow up), and crossover (4 weeks' follow up). The primary outcome of the study will be average percent increase in activity count and will be measured using accelerometer. The secondary measures include exercise self-efficacy, intentions, apps usability and usage.

Phase 2 Following the end of phase 1, a semi-structured interview will be conducted to explore the acceptability and experiences of using the 2 apps (phase 2). The sample will include participants that took part in the crossover trial and consented to being interviewed. Participants that showed frequent usage of the apps, as well as those who used the app infrequently and/or discontinued using the app will be interviewed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • adults (≥18 years' old) identified as "moderately inactive" or "inactive" using General Practice Physical Activity Questionnaire
  • as the use of accelerometer requires some maintenance from the researcher, it was necessary to include only users that reside in/around London for practical reasons
  • willingness to try the apps assessed in the study (walking and workout app)
  • those owning a smartphone, iPhone (operating iOS 6.0 or newer and ) or Android (version 2.3.3 and up
Exclusion Criteria
  • do not speak English
  • previous use of the apps of interest
  • medical conditions that require special attention when conducting physical activity
  • current participation in another research study that targets behaviour change

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Recruitment rates as a percentage of eligible participants that consented to partake in the studyWeek 5

Determined by retention (%)

Secondary Outcome Measures
NameTimeMethod
Retention measured by completeness of data at 5 weeks' follow upWeek 5

Determined by retention (%)

The difference in PA change between the 2 appsWeek 3 and 5

Measured by hip-worn ActiGraph GT3X+

Change in moodWeek 5

Assessed daily using PACO app

Acceptability of the trial procedures and the interventionsWeek 5

Semi-structured interviews following the completion of the trial

Change in exercise self-efficacyWeek 3 and 5

Measured using Self-Efficacy to Regulate Exercise

Change in objectively measured PA from baseline to follow-upWeek 3 and 5

Measured by hip-worn ActiGraph GT3X+

Usage of appsWeek 13

Long-term usage of apps will be assessed by asking participants if they have any of the apps on the phones and if they have used it since the end of the study

Change in PA outcome expectancy measureWeek 3 and 5

Assessed using Physical Activity Outcome Expectancy Measure

Change in self-reported PAWeek 3 and 5

Using International Physical Activity Questionnaires: short last 7 days self-administered format

Usability of the appsWeek 3 and 5

Assessed using System Usability Scale

Trial Locations

Locations (1)

eHealth Unit, Research Department of Primary Care and Population Health, University College London

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath